Lymphomas are classified as Hodgkin’s and Non-Hodgkin’s lymphomas (HL; NHL); NHL being further sub-divided into B, T and Null cell categories on the basis of WHO classification. With a few exceptions worldwide, B-NHL are more common, accounting approximately 80-85% of all cases of NHL compared to T-NHL, which accounts for about 10-15% of all NHL cases. The incidence of NHL has shown a steady increase and attention is being focused on the possible causes of this increase. Epidemiologic studies indicate that environmental factors do play a role in the causation of NHL, such as drugs, pesticides, solvents, hair dyes, viruses (EBV, HTLV-1, Hepatitic C and HIV) and Helicobacter pylori. Hence many different environmental factors of risk acting on...
Abstract Background: Lymphomas are ranked as the sixth most common malignancy worldwide. Endorsing ...
Non-Hodgkin lymphoma (NHL) represents a heterogeneous group of lymphocytic disorders ranging in aggr...
BACKGROUND: Limited information is available from developing countries in patients of non-Hodgkin\u2...
This first population-based study of non- Hodgkin lymphoma (NHL) from any region in Pakistan, provid...
This first population-based study of non- Hodgkin lymphoma (NHL) from any region in Pakistan, provid...
Background: A number of environmental and chemical factors have been thought to been implicated in t...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
There has been a recent concern among oncological clinicians and pathologists of our region regardin...
BACKGROUND: Limited information is available from developing countries in patients of non-Hodgkin's ...
Abstract Background: Lymphomas are ranked as the sixth most common malignancy worldwide. Endorsing ...
Non-Hodgkin lymphoma (NHL) represents a heterogeneous group of lymphocytic disorders ranging in aggr...
BACKGROUND: Limited information is available from developing countries in patients of non-Hodgkin\u2...
This first population-based study of non- Hodgkin lymphoma (NHL) from any region in Pakistan, provid...
This first population-based study of non- Hodgkin lymphoma (NHL) from any region in Pakistan, provid...
Background: A number of environmental and chemical factors have been thought to been implicated in t...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gend...
There has been a recent concern among oncological clinicians and pathologists of our region regardin...
BACKGROUND: Limited information is available from developing countries in patients of non-Hodgkin's ...
Abstract Background: Lymphomas are ranked as the sixth most common malignancy worldwide. Endorsing ...
Non-Hodgkin lymphoma (NHL) represents a heterogeneous group of lymphocytic disorders ranging in aggr...
BACKGROUND: Limited information is available from developing countries in patients of non-Hodgkin\u2...